HealthNotableEmergingDeveloping
4.6
FDA nominee Overton to stress speed, efficiency to counter China in Senate hearing
STAT NewsLO·US · CN·about 1 hour ago
HealthSingle-sourceMedium
5.1
FDA approves Lilly combo for advanced breast cancer
The FDA approved Eli Lilly's combination therapy for advanced breast cancer, expanding treatment options. Approval follows clinical data supporting efficacy, though commercial impact and pricing remain uncertain. This adds to Lilly's oncology portfolio amid competitive pressure in the cancer drug market.
Score Breakdown
Mosaic Score5.1
Confidence0.9
Significance0.5
Source credibility0.1
Related signals
8 foundHealthNotableEmerging
5.4
Novo Nordisk CEO: Pills could capture 50% of obesity drug market by 2030
Valor Econômico·DK · US·2 days ago
JusticeNotableEmergingDeveloping
5.2
Patients Sue Novo Nordisk, Eli Lilly Over Rare Vision Loss Linked to GLP-1 Drugs
InfobaeLO·US·3 days ago
HealthNotableSingle-source
5.1
China approves world's first CAR-T therapy for solid tumors; first foreign patient treated
South China Morning PostLO·CN · NZ·1 day ago
PoliticsNotableSingle-sourceDeveloping
5.1
Trump nominates Dr. Heidi Overton to lead FDA
STAT NewsLO·US · MX·about 6 hours ago
HealthNotableSingle-sourceDeveloping
5.0
FDA advisory vote on Grail's cancer blood test could reshape regulatory path
STAT NewsLO·US·3 days ago
HealthNotableSingle-source
4.8
Bosnian Oncology Patients Protest Unfulfilled Care Promises Ahead of 19th Race for the Cure
N1 BosniaLO·BA·1 day ago
HealthNotableEmergingDeveloping
4.6
FDA nominee Overton to prioritize research speed, counter China's biomedical rise
STAT NewsLO·US · CN·about 16 hours ago